> top > docs > PubMed:19782135 > annotations

PubMed:19782135 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T1 0-9 Q6QHT9 denotes Aromatase
T2 0-9 Q92112 denotes Aromatase
T3 0-9 P11511 denotes Aromatase
T4 0-9 P19098 denotes Aromatase
T5 0-9 Q92111 denotes Aromatase
T6 0-9 P79699 denotes Aromatase
T7 0-9 P28649 denotes Aromatase
T8 0-9 Q29605 denotes Aromatase
T9 0-9 Q5QQX7 denotes Aromatase
T10 0-9 P22443 denotes Aromatase
T11 0-9 Q9XS28 denotes Aromatase
T13 0-9 Q69FB6 denotes Aromatase
T14 0-9 PR:000006100 denotes Aromatase
T15 0-9 Q6YI21 denotes Aromatase
T16 0-9 Q92087 denotes Aromatase
T17 0-9 O46512 denotes Aromatase
T18 0-9 O42145 denotes Aromatase
T19 0-9 Q95M61 denotes Aromatase
T20 0-9 P46194 denotes Aromatase
T21 0-9 P70091 denotes Aromatase
T12 0-9 D001141 denotes Aromatase
T22 22-30 D004967 denotes estrogen
T23 22-30 D004967 denotes estrogen
T24 22-30 CHEBI:50114 denotes estrogen
T26 45-49 CVCL_5552 denotes DCIS
T25 45-49 D002285 denotes DCIS
T27 45-49 D002285 denotes DCIS
T30 51-75 D002285 denotes ductal carcinoma in situ
T31 51-75 D002285 denotes ductal carcinoma in situ
T36 80-85 D006801 denotes human
T37 86-92 UBERON:0000310 denotes breast
T40 101-118 D002278 denotes carcinoma in situ
T41 101-118 D002278 denotes carcinoma in situ
T43 122-126 CVCL_5552 denotes DCIS
T42 122-126 D002285 denotes DCIS
T44 122-126 D002285 denotes DCIS
T45 299-303 UBERON:0000025 denotes duct
T46 299-303 UBERON:0000058 denotes duct
T47 364-373 D004967 denotes estrogens
T48 364-373 D004967 denotes estrogens
T49 364-373 CHEBI:50114 denotes estrogens
T50 430-437 D004194 denotes disease
T51 430-437 D004194 denotes disease
T52 476-487 D006965 denotes hyperplasia
T53 476-487 D006965 denotes hyperplasia
T55 491-495 CVCL_5552 denotes DCIS
T54 491-495 D002285 denotes DCIS
T56 491-495 D002285 denotes DCIS
T57 533-542 D002277 denotes carcinoma
T58 533-542 D002277 denotes carcinoma
T60 548-552 CVCL_5552 denotes DCIS
T59 548-552 D002285 denotes DCIS
T61 548-552 D002285 denotes DCIS
T62 554-562 D004967 denotes Estrogen
T63 554-562 D004967 denotes Estrogen
T64 554-562 CHEBI:50114 denotes Estrogen
T65 554-571 Q9PVZ9 denotes Estrogen receptor
T66 554-571 Q9YHT3 denotes Estrogen receptor
T67 554-571 P57717 denotes Estrogen receptor
T68 554-571 Q9QZJ5 denotes Estrogen receptor
T69 554-571 Q29040 denotes Estrogen receptor
T70 554-571 P49886 denotes Estrogen receptor
T71 554-571 P50240 denotes Estrogen receptor
T72 554-571 Q91424 denotes Estrogen receptor
T73 554-571 Q9YHZ7 denotes Estrogen receptor
T74 554-571 P06211 denotes Estrogen receptor
T75 554-571 P16058 denotes Estrogen receptor
T76 554-571 P50242 denotes Estrogen receptor
T77 554-571 Q53AD2 denotes Estrogen receptor
T78 554-571 P49885 denotes Estrogen receptor
T79 554-571 P49884 denotes Estrogen receptor
T80 554-571 P19785 denotes Estrogen receptor
T81 554-571 Q91250 denotes Estrogen receptor
T82 554-571 P81559 denotes Estrogen receptor
T83 554-571 Q9TV98 denotes Estrogen receptor
T84 554-571 PR:000007204 denotes Estrogen receptor
T85 554-571 Q9YH33 denotes Estrogen receptor
T86 554-571 P50241 denotes Estrogen receptor
T87 554-571 P06212 denotes Estrogen receptor
T88 554-571 P03372 denotes Estrogen receptor
T89 554-571 O42132 denotes Estrogen receptor
T90 554-571 P57753 denotes Estrogen receptor
T91 573-582 Q9PVZ9 denotes ER) alpha
T92 573-582 Q9YHT3 denotes ER) alpha
T93 573-582 P57717 denotes ER) alpha
T94 573-582 Q9QZJ5 denotes ER) alpha
T95 573-582 Q29040 denotes ER) alpha
T96 573-582 P49886 denotes ER) alpha
T97 573-582 P50240 denotes ER) alpha
T98 573-582 Q91424 denotes ER) alpha
T99 573-582 Q9YHZ7 denotes ER) alpha
T100 573-582 P06211 denotes ER) alpha
T101 573-582 P16058 denotes ER) alpha
T102 573-582 P50242 denotes ER) alpha
T103 573-582 Q53AD2 denotes ER) alpha
T104 573-582 P49885 denotes ER) alpha
T105 573-582 P49884 denotes ER) alpha
T106 573-582 P19785 denotes ER) alpha
T107 573-582 Q91250 denotes ER) alpha
T108 573-582 P81559 denotes ER) alpha
T109 573-582 Q9TV98 denotes ER) alpha
T110 573-582 PR:000007204 denotes ER) alpha
T111 573-582 Q9YH33 denotes ER) alpha
T112 573-582 P50241 denotes ER) alpha
T113 573-582 P06212 denotes ER) alpha
T114 573-582 P03372 denotes ER) alpha
T115 573-582 O42132 denotes ER) alpha
T116 573-582 P57753 denotes ER) alpha
T117 577-582 CHEBI:30216 denotes alpha
T118 610-637 D002285 denotes atypical ductal hyperplasia
T119 610-637 D002285 denotes atypical ductal hyperplasia
T123 652-656 CVCL_5552 denotes DCIS
T122 652-656 D002285 denotes DCIS
T124 652-656 D002285 denotes DCIS
T126 698-707 10324 denotes tamoxifen
T125 698-707 D013629 denotes tamoxifen
T127 698-707 CHEBI:41774 denotes tamoxifen
T128 698-707 D013629 denotes tamoxifen
T129 734-744 D012008 denotes recurrence
T130 734-744 D012008 denotes recurrence
T132 748-752 CVCL_5552 denotes DCIS
T131 748-752 D002285 denotes DCIS
T133 748-752 D002285 denotes DCIS
T134 789-798 D002277 denotes carcinoma
T135 789-798 D002277 denotes carcinoma
T136 813-821 D004967 denotes estrogen
T137 813-821 D004967 denotes estrogen
T138 813-821 CHEBI:50114 denotes estrogen
T140 839-843 CVCL_5552 denotes DCIS
T139 839-843 D002285 denotes DCIS
T141 839-843 D002285 denotes DCIS
T142 893-899 37565 denotes tandem
T143 893-899 SO:0001513 denotes tandem
T144 970-976 UBERON:0000310 denotes breast
T145 1036-1045 D002277 denotes carcinoma
T146 1036-1045 D002277 denotes carcinoma
T147 1047-1056 Q6QHT9 denotes Aromatase
T148 1047-1056 Q92112 denotes Aromatase
T149 1047-1056 P11511 denotes Aromatase
T150 1047-1056 P19098 denotes Aromatase
T151 1047-1056 Q92111 denotes Aromatase
T152 1047-1056 P79699 denotes Aromatase
T153 1047-1056 P28649 denotes Aromatase
T154 1047-1056 Q29605 denotes Aromatase
T155 1047-1056 Q5QQX7 denotes Aromatase
T156 1047-1056 P22443 denotes Aromatase
T157 1047-1056 Q9XS28 denotes Aromatase
T159 1047-1056 Q69FB6 denotes Aromatase
T160 1047-1056 PR:000006100 denotes Aromatase
T161 1047-1056 Q6YI21 denotes Aromatase
T162 1047-1056 Q92087 denotes Aromatase
T163 1047-1056 O46512 denotes Aromatase
T164 1047-1056 O42145 denotes Aromatase
T165 1047-1056 Q95M61 denotes Aromatase
T166 1047-1056 P46194 denotes Aromatase
T167 1047-1056 P70091 denotes Aromatase
T158 1047-1056 D001141 denotes Aromatase
T170 1057-1061 SO:0000234 denotes mRNA
T168 1057-1061 D012333 denotes mRNA
T169 1057-1061 CHEBI:33699 denotes mRNA
T172 1114-1118 CVCL_5552 denotes DCIS
T171 1114-1118 D002285 denotes DCIS
T173 1114-1118 D002285 denotes DCIS
T174 1149-1152 Q41249 denotes PCR
T175 1149-1152 O66148 denotes PCR
T176 1149-1152 Q59987 denotes PCR
T177 1149-1152 Q01289 denotes PCR
T178 1149-1152 O80333 denotes PCR
T179 1149-1152 P15904 denotes PCR
T180 1149-1152 Q9SDT1 denotes PCR
T181 1149-1152 Q39617 denotes PCR
T182 1242-1248 UBERON:0000310 denotes breast
T183 1287-1296 D002277 denotes carcinoma
T184 1287-1296 D002277 denotes carcinoma
T185 1322-1331 Q6QHT9 denotes aromatase
T186 1322-1331 Q92112 denotes aromatase
T187 1322-1331 P11511 denotes aromatase
T188 1322-1331 P19098 denotes aromatase
T189 1322-1331 Q92111 denotes aromatase
T190 1322-1331 P79699 denotes aromatase
T191 1322-1331 P28649 denotes aromatase
T192 1322-1331 Q29605 denotes aromatase
T193 1322-1331 Q5QQX7 denotes aromatase
T194 1322-1331 P22443 denotes aromatase
T195 1322-1331 Q9XS28 denotes aromatase
T197 1322-1331 Q69FB6 denotes aromatase
T198 1322-1331 PR:000006100 denotes aromatase
T199 1322-1331 Q6YI21 denotes aromatase
T200 1322-1331 Q92087 denotes aromatase
T201 1322-1331 O46512 denotes aromatase
T202 1322-1331 O42145 denotes aromatase
T203 1322-1331 Q95M61 denotes aromatase
T204 1322-1331 P46194 denotes aromatase
T205 1322-1331 P70091 denotes aromatase
T196 1322-1331 D001141 denotes aromatase
T206 1404-1413 D002277 denotes carcinoma
T207 1404-1413 D002277 denotes carcinoma
T208 1415-1424 Q6QHT9 denotes Aromatase
T209 1415-1424 Q92112 denotes Aromatase
T210 1415-1424 P11511 denotes Aromatase
T211 1415-1424 P19098 denotes Aromatase
T212 1415-1424 Q92111 denotes Aromatase
T213 1415-1424 P79699 denotes Aromatase
T214 1415-1424 P28649 denotes Aromatase
T215 1415-1424 Q29605 denotes Aromatase
T216 1415-1424 Q5QQX7 denotes Aromatase
T217 1415-1424 P22443 denotes Aromatase
T218 1415-1424 Q9XS28 denotes Aromatase
T220 1415-1424 Q69FB6 denotes Aromatase
T221 1415-1424 PR:000006100 denotes Aromatase
T222 1415-1424 Q6YI21 denotes Aromatase
T223 1415-1424 Q92087 denotes Aromatase
T224 1415-1424 O46512 denotes Aromatase
T225 1415-1424 O42145 denotes Aromatase
T226 1415-1424 Q95M61 denotes Aromatase
T227 1415-1424 P46194 denotes Aromatase
T228 1415-1424 P70091 denotes Aromatase
T219 1415-1424 D001141 denotes Aromatase
T229 1457-1463 UBERON:0000310 denotes breast
T230 1464-1476 D009369 denotes malignancies
T231 1464-1476 D009369 denotes malignancies
T233 1487-1491 CVCL_5552 denotes DCIS
T232 1487-1491 D002285 denotes DCIS
T234 1487-1491 D002285 denotes DCIS
T238 1547-1556 4083 denotes estradiol
T235 1547-1556 CHEBI:16469 denotes estradiol
T236 1547-1556 CHEBI:23965 denotes estradiol
T237 1547-1556 D004958 denotes estradiol
T239 1547-1556 D004958 denotes estradiol
T240 1628-1637 Q6QHT9 denotes aromatase
T241 1628-1637 Q92112 denotes aromatase
T242 1628-1637 P11511 denotes aromatase
T243 1628-1637 P19098 denotes aromatase
T244 1628-1637 Q92111 denotes aromatase
T245 1628-1637 P79699 denotes aromatase
T246 1628-1637 P28649 denotes aromatase
T247 1628-1637 Q29605 denotes aromatase
T248 1628-1637 Q5QQX7 denotes aromatase
T249 1628-1637 P22443 denotes aromatase
T250 1628-1637 Q9XS28 denotes aromatase
T252 1628-1637 Q69FB6 denotes aromatase
T253 1628-1637 PR:000006100 denotes aromatase
T254 1628-1637 Q6YI21 denotes aromatase
T255 1628-1637 Q92087 denotes aromatase
T256 1628-1637 O46512 denotes aromatase
T257 1628-1637 O42145 denotes aromatase
T258 1628-1637 Q95M61 denotes aromatase
T259 1628-1637 P46194 denotes aromatase
T260 1628-1637 P70091 denotes aromatase
T261 1628-1648 D047072 denotes aromatase inhibitors
T262 1628-1648 D047072 denotes aromatase inhibitors
T263 1628-1648 CHEBI:50790 denotes aromatase inhibitors
T266 1682-1686 CVCL_5552 denotes DCIS
T265 1682-1686 D002285 denotes DCIS
T267 1682-1686 D002285 denotes DCIS

Allie

Id Subject Object Predicate Lexical cue
SS1_19782135_0_0 51-75 expanded denotes ductal carcinoma in situ
SS2_19782135_0_0 45-49 abbr denotes DCIS
SS1_19782135_3_0 554-571 expanded denotes Estrogen receptor
SS2_19782135_3_0 573-575 abbr denotes ER
AE1_19782135_0_0 SS1_19782135_0_0 SS2_19782135_0_0 abbreviatedTo ductal carcinoma in situ,DCIS
AE1_19782135_3_0 SS1_19782135_3_0 SS2_19782135_3_0 abbreviatedTo Estrogen receptor,ER

UseCases_ArguminSci_Discourse

Id Subject Object Predicate Lexical cue
T1 0-93 DRI_Background denotes Aromatase and in situ estrogen production in DCIS (ductal carcinoma in situ) of human breast.
T2 94-318 DRI_Background denotes Ductal carcinoma in situ or DCIS belongs to intraductal proliferative lesions, which are a group of cytologically and architecturally diverse ductal proliferations, typically originating from the terminal duct-lobular units.
T3 319-553 DRI_Challenge denotes In these intraductal proliferative diseases, estrogens are considered to be involved in the progression of the disease especially from ductal non-neoplastic hyperplasia to DCIS and possibly development of invasive carcinoma from DCIS.
T4 554-657 DRI_Background denotes Estrogen receptor (ER) alpha is abundantly expressed in atypical ductal hyperplasia and low grade DCIS.
T5 658-799 DRI_Outcome denotes Suppression of estrogenic actions using tamoxifen resulted in inhibition of recurrence of DCIS and/or of progression into invasive carcinoma.
T6 800-1046 DRI_Background denotes Intratumoral estrogen concentration in DCIS determined by liquid chromatography/electrospray tandem mass spectrometry is significantly higher than that in non-neoplastic breast tissues with statistically not lower than that in invasive carcinoma.
T7 1047-1297 DRI_Background denotes Aromatase mRNA expression in both stromal and parenchymal cells of DCIS determined by quantitative RT-PCR following laser capture microdissection was also much higher than that in non-neoplastic breast, although lower than that in invasive carcinoma.
T8 1298-1414 DRI_Background denotes Immunohistochemistry of aromatase also revealed the similar patterns of immunolocalization as in invasive carcinoma.
T9 1415-1557 DRI_Background denotes Aromatase is overexpressed in noninvasive breast malignancies including DCIS and results in elevated concentrations of intratumoral estradiol.
T10 1558-1696 DRI_Background denotes These findings could provide the scientific rationale as to employing aromatase inhibitors in the management of ER positive DCIS patients.

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T1 94-318 DRI_Background denotes Ductal carcinoma in situ or DCIS belongs to intraductal proliferative lesions, which are a group of cytologically and architecturally diverse ductal proliferations, typically originating from the terminal duct-lobular units.
T2 319-553 DRI_Challenge denotes In these intraductal proliferative diseases, estrogens are considered to be involved in the progression of the disease especially from ductal non-neoplastic hyperplasia to DCIS and possibly development of invasive carcinoma from DCIS.
T3 554-657 DRI_Background denotes Estrogen receptor (ER) alpha is abundantly expressed in atypical ductal hyperplasia and low grade DCIS.
T4 658-799 DRI_Outcome denotes Suppression of estrogenic actions using tamoxifen resulted in inhibition of recurrence of DCIS and/or of progression into invasive carcinoma.
T5 800-1046 DRI_Background denotes Intratumoral estrogen concentration in DCIS determined by liquid chromatography/electrospray tandem mass spectrometry is significantly higher than that in non-neoplastic breast tissues with statistically not lower than that in invasive carcinoma.
T6 1047-1297 DRI_Background denotes Aromatase mRNA expression in both stromal and parenchymal cells of DCIS determined by quantitative RT-PCR following laser capture microdissection was also much higher than that in non-neoplastic breast, although lower than that in invasive carcinoma.
T7 1298-1414 DRI_Background denotes Immunohistochemistry of aromatase also revealed the similar patterns of immunolocalization as in invasive carcinoma.
T8 1415-1557 DRI_Background denotes Aromatase is overexpressed in noninvasive breast malignancies including DCIS and results in elevated concentrations of intratumoral estradiol.
T9 1558-1696 DRI_Background denotes These findings could provide the scientific rationale as to employing aromatase inhibitors in the management of ER positive DCIS patients.